1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with mastoparan in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (mastoparan) | Trials (mastoparan) | Recent Studies (post-2010) (mastoparan) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 553 | 1 | 72 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chakrabarti, R; Erickson, KL; Hubbard, NE; Lim, D | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and mastoparan
Article | Year |
---|---|
Alteration of platelet-activating factor-induced signal transduction in macrophages by n-3 fatty acids.
Topics: Animals; Calcium; Estrenes; Fatty Acids, Omega-3; Female; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Kinetics; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Peptides; Phosphodiesterase Inhibitors; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyrrolidinones; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Signal Transduction; Type C Phospholipases; Wasp Venoms | 1997 |